These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22676459)

  • 1. Relation between augmentation index and adiponectin during one-year metformin treatment for nonalcoholic steatohepatosis: effects beyond glucose lowering?
    Shargorodsky M; Omelchenko E; Matas Z; Boaz M; Gavish D
    Cardiovasc Diabetol; 2012 Jun; 11():61. PubMed ID: 22676459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment with insulin sensitizer metformin improves arterial properties, metabolic parameters, and liver function in patients with nonalcoholic fatty liver disease: a randomized, placebo-controlled trial.
    Sofer E; Boaz M; Matas Z; Mashavi M; Shargorodsky M
    Metabolism; 2011 Sep; 60(9):1278-84. PubMed ID: 21411114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of the effects of Chlorella vulgaris supplementation in patients with non-alcoholic fatty liver disease: a randomized clinical trial.
    Panahi Y; Ghamarchehreh ME; Beiraghdar F; Zare R; Jalalian HR; Sahebkar A
    Hepatogastroenterology; 2012 Oct; 59(119):2099-2103. PubMed ID: 23234816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adiponectin is better predictor of subclinical atherosclerosis than liver function tests in patients with nonalcoholic fatty liver disease.
    Omelchenko E; Gavish D; Shargorodsky M
    J Am Soc Hypertens; 2014 Jun; 8(6):376-80. PubMed ID: 24794207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of high doses of vitamin D on arterial properties, adiponectin, leptin and glucose homeostasis in type 2 diabetic patients.
    Breslavsky A; Frand J; Matas Z; Boaz M; Barnea Z; Shargorodsky M
    Clin Nutr; 2013 Dec; 32(6):970-5. PubMed ID: 23561637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effects of aerobic plus resistance training on the adipokines and neuropeptides in nonalcoholic fatty liver disease obese adolescents.
    de Piano A; de Mello MT; Sanches Pde L; da Silva PL; Campos RM; Carnier J; Corgosinho F; Foschini D; Masquio DL; Tock L; Oyama LM; do Nascimento CM; Tufik S; Dâmaso AR
    Eur J Gastroenterol Hepatol; 2012 Nov; 24(11):1313-24. PubMed ID: 22932160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exenatide improves type 2 diabetes concomitant with non-alcoholic fatty liver disease.
    Fan H; Pan Q; Xu Y; Yang X
    Arq Bras Endocrinol Metabol; 2013 Dec; 57(9):702-8. PubMed ID: 24402015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of metformin treatment on circulating osteoprotegerin in patients with nonalcoholic fatty liver disease.
    Sofer E; Shargorodsky M
    Hepatol Int; 2016 Jan; 10(1):169-74. PubMed ID: 26198758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study.
    Nobili V; Manco M; Ciampalini P; Alisi A; Devito R; Bugianesi E; Marcellini M; Marchesini G
    Clin Ther; 2008 Jun; 30(6):1168-76. PubMed ID: 18640473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin in patients with non-alcoholic fatty liver disease: a randomized, controlled trial.
    Haukeland JW; Konopski Z; Eggesbø HB; von Volkmann HL; Raschpichler G; Bjøro K; Haaland T; Løberg EM; Birkeland K
    Scand J Gastroenterol; 2009; 44(7):853-60. PubMed ID: 19811343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic effect of metformin and vitamin E versus prescriptive diet in obese adolescents with fatty liver.
    Akcam M; Boyaci A; Pirgon O; Kaya S; Uysal S; Dundar BN
    Int J Vitam Nutr Res; 2011 Nov; 81(6):398-406. PubMed ID: 22673924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic effects of insulin-sensitizing drugs on nonalcoholic fatty liver disease: experiment with rats].
    Zhang DM; Zhang GY; Wang T; Zhong HJ; Chen WK
    Zhonghua Yi Xue Za Zhi; 2006 May; 86(18):1279-83. PubMed ID: 16796890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial.
    Lavine JE; Schwimmer JB; Van Natta ML; Molleston JP; Murray KF; Rosenthal P; Abrams SH; Scheimann AO; Sanyal AJ; Chalasani N; Tonascia J; Ünalp A; Clark JM; Brunt EM; Kleiner DE; Hoofnagle JH; Robuck PR;
    JAMA; 2011 Apr; 305(16):1659-68. PubMed ID: 21521847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effect of Metformin on Aminotransferase Levels, Metabolic Parameters and Body Mass Index in Nonalcoholic Fatty Liver Disease Patients: A Metaanalysis.
    Hu H; Wang J; Li X; Shen L; Shi D; Meng J
    Curr Pharm Des; 2021; 27(29):3235-3243. PubMed ID: 33719959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does metformin treatment influence bone formation in patients with nonalcoholic fatty liver disease?
    Soifer E; Gavish D; Shargorodsky M
    Horm Metab Res; 2015 Jul; 47(8):556-9. PubMed ID: 25671801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic Effect of Metformin on Chemerin in Non-Obese Patients with Non-Alcoholic Fatty Liver Disease (NAFLD).
    Zhuang X; Sun F; Li L; Jiang D; Li X; Sun A; Pan Z; Lou N; Zhang L; Lou F
    Clin Lab; 2015; 61(10):1409-14. PubMed ID: 26642701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Irisin in patients with nonalcoholic fatty liver disease.
    Polyzos SA; Kountouras J; Anastasilakis AD; Geladari EV; Mantzoros CS
    Metabolism; 2014 Feb; 63(2):207-17. PubMed ID: 24140091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease.
    Bugianesi E; Gentilcore E; Manini R; Natale S; Vanni E; Villanova N; David E; Rizzetto M; Marchesini G
    Am J Gastroenterol; 2005 May; 100(5):1082-90. PubMed ID: 15842582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of pioglitazone and metformin on plasma adiponectin in newly detected type 2 diabetes mellitus.
    Sharma PK; Bhansali A; Sialy R; Malhotra S; Pandhi P
    Clin Endocrinol (Oxf); 2006 Dec; 65(6):722-8. PubMed ID: 17121522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Empagliflozin on top of metformin treatment improves arterial function in patients with type 1 diabetes mellitus.
    Lunder M; Janić M; Japelj M; Juretič A; Janež A; Šabovič M
    Cardiovasc Diabetol; 2018 Dec; 17(1):153. PubMed ID: 30509271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.